Abstract
Background The COVID-19 virtual ward was created to provide care for people at home with COVID-19. Only a small proportion required hospital admission during their care. Given this was a new model of care, little was known about the clinical characteristics and outcomes of patients requiring admission to hospital from the virtual ward platform.
Aim A retrospective observational study with the aim to characterise hospital admission volume, patient epidemiology, clinical characteristics and outcome form a virtual ward in the setting of an Omicron BA.1 and BA.2 outbreak.
Methods A retrospective observational study was performed for all virtual ward patients admitted from 1st January 2022 to 25th March 2022. Patients had to be at least 16 years old to be included. Epidemiological, clinical and laboratory data was reviewed on all patients who required admission to hospital. This was analysed to describe this patient cohort.
Results A total of 7021 patients were cared for on the virtual ward over the study period with 473 referred to hospital for assessment. Twenty-six (0.4%) patients were admitted to hospital during their care on the ward. Twenty-two (84.6%) admissions were COVID-19 related. Fifty three percent of the hospitalised patients were fully vaccinated, and 11 had received prior therapeutics for COVID-19 in the community. There was one ICU admission, and one in-hospital mortality. Shortness of breath was the most common reason for escalation to hospital. Chest pain was the second most common reason and the most common diagnosis after investigation was non-cardiac chest pain that spontaneously resolved.
Conclusions Few patients required admission from the virtual ward in the setting of the Omicron variant (BA.1, BA.2) as a direct result of COVID-19 disease and virtual ward care. Shortness of breath and chest pain were the most common symptoms driving further clinical care.
What does this paper add to the literature?This paper describes the patient cohort with COVID-19 (Omicron variant) who are unable to be cared for by the virtual model of care and required escalation for hospital admission. It assists in health service planning in the setting of large numbers of cases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Royal Brisbane and Womens Hospital Human Research Ethics Committee of Royal Brisbane and Womens Hospital gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declarations: No funding was received for this study.
Declarations of interest: none
All relevant ethical guidelines have been followed. Ethics approval was granted by the Royal Brisbane and Women’s Hospital Human Research Ethics Committee (Approval number: EX/2022/QRBW/84877).
There was no material reproduced from other sources. This study was not registered on a clinical trials registry.
Data Availability
All data produced in the present work are contained in the manuscript.